회원가입 | 연락처 | 사이트맵 | English

      회사소개 | 리포트 | 커스텀 리서치 | 고객지원
엘앤에치


로그인

카테고리

유/무선통신

전기/전자

디지털기기/미디어/방송

Information Technology

에너지

생명공학

화학/신소재

자동차

환경

일반소비재

마케팅/광고

금융

건설

교통/운송

소비자조사

방위/항공/우주

식음료

중공업

교육

기계

무역

스포츠/레저

해운/조선

패션

정부/정책

공예/귀금속

컴퍼니 프로파일

기타산업

 
현재위치 : HOME > 리포트 > 정보제공업체
정보제공업체 : GBI Research

인쇄하기  
리포트 제목 발행일 발행사 가격

Biobanking: Developing Smart, Sustainable and Ethically Compliant Biorepositories for the Future

2015년 12월 GBI Research $2,995

Frontier Pharma: Duchenne Muscular Dystrophy and Becker Muscular Dystrophy - Identifying and Commercializing First-in-Class Innovation

2015년 05월 GBI Research $6,995

Frontier Pharma: Asthma - Identifying and Commercializing First-in-Class Innovation

2015년 05월 GBI Research $6,995

MRI Systems Market to 2020 - Focus on Patient Comfort and Operational Efficiency, with Growth Driven by Developing Economies

2015년 04월 GBI Research $3,500

Frontier Pharma: Parkinson’s Disease - Identifying and Commercializing First-in-Class Innovation

2014년 11월 GBI Research $6,995

Frontier Pharma: Prostate Cancer - Identifying and Commercializing First-in-Class Innovation

2014년 11월 GBI Research $6,995

Type 2 Diabetes Therapeutics in Asia-Pacific Markets to 2020 - Increasing Uptake of Novel Drug Classes to Drive Market Growth

2014년 11월 GBI Research $4,995

Market Snapshot: Aesthetic Lasers and Energy Devices Market 2006 to 2020 - Asia-Pacific

2014년 11월 GBI Research $1,750

Non-Hodgkin Lymphoma Therapeutics in Major Developed Markets to 2020 - New Entrants and Promising Pipeline Widen Targeted and Immunotherapeutic Treatment Options

2014년 10월 GBI Research $4,995

Major Depressive Disorder Therapeutics in Major Developed Markets to 2020 - New Launches and Modest Uptake of New Adjunctive Treatments to Offset Patent Expiries

2014년 10월 GBI Research $4,995

Frontier Pharma: Non-Small Cell Lung Cancer - Identifying and Commercializing First-in-Class Innovation

2014년 10월 GBI Research $6,995

Market Snapshot: Cardiac Rhythm Management Devices 2006 to 2020 - US and Europe (US, Germany, France, Italy, UK, Spain)

2014년 10월 GBI Research $1,750

Non-Hodgkin Lymphoma Therapeutics in Asia-Pacific Markets to 2020 - Novel Technologies Show Considerable Promise in Relapsed/Refractory Setting

2014년 09월 GBI Research $4,995

Market Snapshot: Mammography Systems 2006 to 2020 - Americas (US, Canada, Brazil, Mexico)

2014년 09월 GBI Research $1,750

Non-Small Cell Lung Cancer Market to 2020 - New Therapies to Enhance Treatment Segmentation and Drive Growth in an Increasingly Competitive Market

2014년 07월 GBI Research $4,995

Market Snapshot: Transcatheter Heart Valves 2007 to 2020 - Americas (US, Canada, Brazil, Mexico)

2014년 07월 GBI Research $1,750

Critical Care Therapeutics in Major Developed Markets to 2020 - New and Late-Stage Four-Factor PCCs and Recombinant Products to Drive Market

2014년 07월 GBI Research $4,995

Market Snapshot: Mammography Systems 2006 to 2020 - Europe (Germany, UK, France, Italy, Spain)

2014년 07월 GBI Research $1,750

Market Snapshot: Mammography Systems 2006 to 2020 - Asia-Pacific (China, Japan, South Korea, Australia and India)

2014년 06월 GBI Research $1,750

Antihypertensive Therapeutics in Major Developed Markets to 2020 - Increased Uptake of Combination Therapies to Offset Effects of Key Patent Expiries

2014년 06월 GBI Research $4,995

Breast Cancer Therapeutics in Major Developed Markets to 2020 - Approval of Novel Therapies to Support Continued Dominance of HER2 Targeted Drugs

2014년 06월 GBI Research $4,995

Frontier Pharma: Psoriasis - Identifying and Commercializing First-in-Class Innovation

2014년 05월 GBI Research $6,995

Facial Aesthetics Market to 2020 - Economic Recovery Drives Growth in the US as Increasing Awareness Fuels Demand in Developing Markets

2014년 05월 GBI Research $3,500

Breast Cancer Therapeutics in Asia-Pacific Markets to 2020 - Novel HER-2 Positive Therapies Provide Diversified Treatment Options

2014년 05월 GBI Research $4,995

Ovarian Cancer Therapeutics in Major Developed Markets to 2020 - Late-Stage Pipeline Focuses on Improved Progression Free-Surival and Targeted Therapies

2014년 05월 GBI Research $4,995
  1    2    3    4    5    6    7    8    9    10   

회사소개 | 개인정보보호정책 | 이용약관 | 배송/결제안내 | 이용안내

서울시 강남구 논현동 210-1 삼원빌딩 | 회사명 : (주)엘앤에치
대표전화 : 02-554-0001 / 팩스 : 02-3444-5501 / 이메일 : sales@landh.co.kr
Copyright ⓒ 2008 LNH, Inc. All rights reserved.